Role of luteal phase support on gonadotropin ovulation induction cycles in patients with polycystic ovary syndrome

Journal of Reproductive Medicine

Volumn 59, Issue 1-2, 2014, Pages 25-30

  Yazici, Gurkan ^a   Savas, Aysun ^a   Tasdelen, Bahar ^a   Dilek, Saffet ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Assisted reproduction techniques; In vitro fertilization; Infertility; Intrauterine insemination; Luteal phase support; Ovulation induction; Polycystic ovary syndrome; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ANOVULATION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HORMONAL THERAPY; HUMAN; INFERTILITY; INTRAUTERINE INSEMINATION; LIVE BIRTH; LUTEAL PHASE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; CLOMIPHENE; DRUG RESISTANCE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL; LIVE BIRTH; LUTEAL PHASE; MALE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; RECOMBINANT PROTEINS;

EID: 84892861890     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Goodarzi MO, Dumesic DA, Chazenbalk G, et al: Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-231
2. Conway GS, Honour JW, Jacobs HS: Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989;30:459-470
3. Hughes E, Collins J, Vandekerckhove P: Clomiphene citrate for ovulation induction in women with oligoamenorrhoea. Cochrane Database Syst Rev 2000:CD000056
4. Stadtmauer L, Oehninger S: Management of infertility in women with polycystic ovary syndrome: A practical guide. Treat Endocrinol 2005;4:279-292
5. Daya S: Luteal support: Progestogens for pregnancy protection. Maturitas 2009;65S:29-34
6. Fatemi HM, Popovic-Todorovic B, Papanikolaou E, et al: An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 2007;13:581-590
7. Erdem A, Erdem M, Atmaca S, et al: Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: A prospective randomized study. Fertil Steril 2009; 91:2508-2513
8. Maher MA: Luteal phase support may improve pregnancy outcomes during intrauterine insemination cycles. Eur J Obstet Gynecol Reprod Biol 2011;157:57-62
9. Montville C, Khabbaz M, Aubuchon M, et al: Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation induction. Fertil Steril 2010;94:678-683
10. Kyrou D, Fatemi HM, Tournaye H, et al: Luteal phase support in normoovulatory women stimulated with clomiphene citrate for intrauterine insemination: Need or habit? Hum Reprod 2010;25:2501-2506
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
12. Nugent D, Vanderkerchove P, Hughes E, et al: Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2000:CD000410
13. Fauser BC, Devroey P: Reproductive biology and IVF: Ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 2003;14:236-242
14. Hamilton CJ, Jaroudi KA, Sieck UV: The value of luteal support with progesterone in gonadotropin-induced cycles. Fertil Steril 1993;60:786-790
15. Van der Meer M, Hompes P, de Boer J, et al: Cohort size rather than follicle-stimulating hormone threshold levels determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 1988;83:423-426
16. The ESHRE Capri Workshop Group: Intrauterine insemination. Hum Reprod Update 2009;15:265-277
17. Abu-Heija AT, Fleming R, Yates RW, et al: Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: Comparisons in patients with normal or elevated luteinizing hormone. Hum Reprod 1995;10:3317-3319
18. Doldi N, Gessi A, Destefani A, et al: Polycystic ovary syndrome: Anomalies in progesterone production. Hum Reprod 1998;13:290-293
19. Erickson GF, Magoffin DA, Garzo VG, et al: Granulosa cells of polycystic ovaries: Are they normal or abnormal? Hum Reprod 1992;7:293-299
20. Andreani CL, Pierro E, Lazzarin N, et al: Effect of follicular fluid on granulosa luteal cells from polycystic ovary. Hum Reprod 1996;1:2107-2113
21. Mitwally MF, Abdel-Razeq S, Casper RF: Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination. Reprod Biol Endocrinol 2004;2:55
22. Detti L, Mitwally MF, Rode A, et al: Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles. Fertil Steril 2007;88:152-155
23. van der Linden M, Buckingham K, Farquhar C, et al: Luteal phase support for assisted reproduction cycles (review). Cochrane Database Syst Rev 2011;(10):CD009154
24. Unfer V, Casini ML, Marelli G, et al: Different routes of progesterone administration and polycystic ovary syndrome: A review of the literature. Gynecol Endocrinol 2005;21:119-127